Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2021-11-15 00:00:00 ET · period of report 2021-11-11 · accession 0001062993-21-010826 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-15 | 2021-11-11+ | BIO | TUMOLO ANNETTE | EVP | M - OptEx | $283.49 | +6,346 | 6,139 | New | +$1.80M |
| DM | 2021-11-15 | 2021-11-11+ | BIO | TUMOLO ANNETTE | EVP | S - Sale+OE | $749.79 | -6,346 | 4,593 | -58% | -$4.76M |
| DM | 2021-11-15 | 2021-11-11+ | BIO | TUMOLO ANNETTE | EVP | M - OptEx | $0.00 | -6,346 | 600 | -91% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2021-11-11 | M | A | 613 | $333.34 | 5,206.35 | D | — | — | |
| 2 | Common | Bio-Rad A Common Stock | 2021-11-11 | M | A | 500 | $333.34 | 5,706.35 | D | — | — | |
| 3 | Common | Bio-Rad A Common Stock | 2021-11-11 | S | D | 433 | $748.08 | 5,706.35 | D | — | — | |
| 4 | Common | Bio-Rad A Common Stock | 2021-11-11 | S | D | 613 | $748.84 | 5,093.35 | D | — | — | |
| 5 | Common | Bio-Rad A Common Stock | 2021-11-11 | S | D | 500 | $750.00 | 4,593.35 | D | — | — | |
| 6 | Common | Bio-Rad A Common Stock | 2021-11-12 | M | A | 600 | $159.32 | 5,193.35 | D | — | — | |
| 7 | Common | Bio-Rad A Common Stock | 2021-11-12 | M | A | 2,400 | $215.98 | 7,593.35 | D | — | — | |
| 8 | Common | Bio-Rad A Common Stock | 2021-11-12 | M | A | 1,800 | $326.15 | 9,393.35 | D | — | — | |
| 9 | Common | Bio-Rad A Common Stock | 2021-11-12 | S | D | 4,800 | $750.05 | 4,593.35 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $750.00 to $750.61, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 10 | Common | Bio-Rad A Common Stock | 2021-11-11 | M | A | 433 | $524.30 | 6,139.35 | D | — | — | |
| 11 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-11-11 | M | D | 1,113 | $0.00 | 1,671 | D | $333.34 · — to 2029-09-03 | 1,113 Bio-Rad A Common Stock | (F3) The option, representing a right to purchase a total of 2,784 shares, became exercisable in five equal annual installments beginning on September 3, 2020, which was the first anniversary of the date on which the option was granted. |
| 12 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-11-11 | M | D | 433 | $0.00 | 1,300 | D | $524.30 · — to 2030-09-02 | 433 Bio-Rad A Common Stock | (F2) The option, representing a right to purchase a total of 1,733 shares, became exercisable in four equal annual installments beginning on September 2, 2021, which was the first anniversary of the date on which the option was granted. |
| 13 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-11-12 | M | D | 600 | $0.00 | 0 | D | $159.32 · — to 2026-09-07 | 600 Bio-Rad A Common Stock | (F6) The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted. |
| 14 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-11-12 | M | D | 1,800 | $0.00 | 1,200 | D | $326.15 · — to 2028-09-04 | 1,800 Bio-Rad A Common Stock | (F4) The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 4, 2019, which was the first anniversary of the date on which the option was granted. |
| 15 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-11-12 | M | D | 2,400 | $0.00 | 600 | D | $215.98 · — to 2027-09-05 | 2,400 Bio-Rad A Common Stock | (F5) The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 5, 2018, which was the first anniversary of the date on which the option was granted. |